Matthias Hebben

691 total citations
11 papers, 406 citations indexed

About

Matthias Hebben is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Matthias Hebben has authored 11 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Matthias Hebben's work include Virus-based gene therapy research (10 papers), Herpesvirus Infections and Treatments (4 papers) and Poxvirus research and outbreaks (4 papers). Matthias Hebben is often cited by papers focused on Virus-based gene therapy research (10 papers), Herpesvirus Infections and Treatments (4 papers) and Poxvirus research and outbreaks (4 papers). Matthias Hebben collaborates with scholars based in France, United States and Australia. Matthias Hebben's co-authors include Chiara Bovolenta, Otto-Wilhelm Merten, Philippe Moullier, Richard Redon, Otto‐Wilhelm Merten, Véronique Blouin, Pierre Lindenbaum, Benjamin Cogné, Achille François and Adrien Léger and has published in prestigious journals such as PLoS ONE, Journal of Virology and Vaccine.

In The Last Decade

Matthias Hebben

11 papers receiving 400 citations

Peers

Matthias Hebben

GENET

ONCOL

VIROL

Amanda M. Dudek United States

Nicolas Laroudie France

Hayley E. Raymond United States

Tetsuro Komatsu Japan

Mark Horn United Kingdom

Wenqin Ma United States

Gene-Errol Ringpis United States

Kamola Saydaminova United States

Anke Muth Germany

Cordula Leurs Germany

Amanda M. Dudek United States

Matthias Hebben

271 ×0.9

200 ×0.7

GENET

43 ×0.5

ONCOL

44 ×0.5

23 ×0.9

VIROL

Citations per year, relative to Matthias Hebben Matthias Hebben (= 1×) peers Amanda M. Dudek

Countries citing papers authored by Matthias Hebben

Since Specialization

Citations

This map shows the geographic impact of Matthias Hebben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Hebben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Hebben more than expected).

Fields of papers citing papers by Matthias Hebben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Hebben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Hebben. The network helps show where Matthias Hebben may publish in the future.

Co-authorship network of co-authors of Matthias Hebben

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Hebben. A scholar is included among the top collaborators of Matthias Hebben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Hebben. Matthias Hebben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lee, William, et al.. (2024). A Comprehensive Study of the Effects by Sequence Truncation within Inverted Terminal Repeats (ITRs) on the Productivity, Genome Packaging, and Potency of AAV Vectors. Microorganisms. 12(2). 310–310. 2 indexed citations

Zhang, Shengwen, Susana Gordo, Elizabeth A. McCarthy, et al.. (2022). Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia. PLoS ONE. 17(9). e0274774–e0274774. 5 indexed citations

Cabanes‐Creus, Marti, Erhua Zhu, Sophia H.Y. Liao, et al.. (2021). Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8. Molecular Therapy — Methods & Clinical Development. 24. 88–101. 24 indexed citations

Hebben, Matthias. (2018). Downstream bioprocessing of AAV vectors: industrial challenges & regulatory requirements. Cell and Gene Therapy Insights. 4(2). 131–146. 31 indexed citations

Toueille, Magali, et al.. (2018). Development of purification steps for several AAV serotypes using POROS™ CaptureSelect™ AAVX affinity chromatography. Cell and Gene Therapy Insights. 4(7). 637–645. 14 indexed citations

Champion-Arnaud, Patrick, et al.. (2016). The EB66® cell line as a valuable cell substrate for MVA-based vaccines production. Vaccine. 34(48). 5878–5885. 14 indexed citations

Merten, Otto-Wilhelm, Matthias Hebben, & Chiara Bovolenta. (2016). Production of lentiviral vectors. Molecular Therapy — Methods & Clinical Development. 3. 16017–16017. 207 indexed citations

Cogné, Benjamin, Pierre Lindenbaum, Matthias Hebben, et al.. (2015). Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing. Molecular Therapy — Nucleic Acids. 4. e260–e260. 62 indexed citations

Ferrier-Rembert, Audrey, Matthias Hebben, Danièle Spehner, et al.. (2011). Deletion of Major Nonessential Genomic Regions in the Vaccinia Virus Lister Strain Enhances Attenuation without Altering Vaccine Efficacy in Mice. Journal of Virology. 85(10). 5016–5026. 15 indexed citations

10.

Hebben, Matthias, Catherine Birck, Jean‐Pierre Samama, et al.. (2007). High level protein expression in mammalian cells using a safe viral vector: Modified vaccinia virus Ankara. Protein Expression and Purification. 56(2). 269–278. 18 indexed citations

11.

Hebben, Matthias, et al.. (2004). Modified vaccinia virus Ankara as a vaccine against feline coronavirus: Immunogenicity and efficacy. Journal of Feline Medicine and Surgery. 6(2). 111–118. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact